Clinical Trial Update: A Study of Pemetrexed in Recurrent Cervical Adenocarcinomas [Phase 2]

View source ↗

Summary

Phase 2 trial of pemetrexed in recurrent cervical adenocarcinomas and adenosquamous carcinoma of the cervix was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenosquamous Carcinoma of the Cervix
• Cervical Adenocarcinoma

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: Western Regional Medical Center | Conditions: Adenocarcinoma of the Cervix, Adenosquamous Cell Carcinoma of the Cervix | Phase 2 | Status: TERMINATED | Results posted: 2018-11-02